ArticleBMC research notes2025
Validity and reliability of the persian version of the dyspnea-12 questionnaire in assessing dyspnea among COPD patients.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chronic Obstructive Pulmonary Disease in Never-Smokers-A Distinct Entity Within the COPD Spectrum.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDyspnea is a distressing symptom of Chronic Obstructive Pulmonary Disease (COPD). The Dyspnea-12 questionnaire, a well-established instrument for assessing different dimensions of dyspnea validated in multiple languages, lacked a Persian version. This study aimed to adapt and validate a Persian version of Dyspnea-12.
resultsThe Persian version of Dyspnea-12 demonstrated excellent reliability (Cronbach's alpha = 0.982, Composite Reliability = 0.985). Criterion validity analysis strongly correlated with Dyspnea-12 and CAT scores (ρ = 0.698, p < 0.001). Factor analysis confirmed a single-factor structure consistent with the original version. Inter-item correlations ranged from 0.3 to 0.9. Construct validity indices indicated a satisfactory model fit (CFI = 0.904, SRMR = 0.044), though RMSEA (0.188) suggested areas for improvement. Pulmonary function analysis revealed significant associations between FEV₁ and Dyspnea-12 scores (p = 0.042) and FVC (p = 0.017), linking dyspnea severity with lung function decline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.